PMC Group International Inc., an independent arm of Mount Laurel-based PMC Group Cos., has acquired the Pennsylvania maker of nitroglycerin, it announced recently.
PMC Group, a global chemicals and pharmaceuticals company, said it has acquired Cobra Investments Management Inc. and two subsidiaries, Copperhead Chemical Co. Inc. — the chemical manufacturer — and Copperhead Investments Inc.
Copperhead Chemical is located at a 53-building, 875-acre facility in Tamaqua. PMC described it as the sole maker of the cardiac therapeutic drug nitroglycerin in the U.S. for more than 70 years. The company also makes drug dosage forms, energetic chemicals — explosives and propellants — for the defense industry and more.
“The acquisition of Copperhead and its associated companies increases our penetration of the pharma market,” PMC Group International President Raj Chakrabarti said in a prepared statement. “This new acquisition will fit neatly and synergistically with our other pharmaceutical services and manufacturing companies.”
